Processa Pharmaceuticals Inc (PCSA)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.17M | -6.06M | -13.07M | -4.11M | -2.72M | -2.17M | -2.47M | -2.81M |
| Pre Tax Income | -5.16M | -6.02M | -13.01M | -4.02M | -2.61M | -2.08M | -2.41M | -2.73M |
| Net Income | -5.16M | -6.02M | -13.01M | -4.02M | -2.61M | -2.08M | -2.41M | -2.73M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -5.17M | -6.06M | -13.07M | -4.02M | -2.61M | -2.17M | -2.47M | -2.81M |
| EBITDA | -4.97M | -5.86M | -5.6M | -4.11M | -2.72M | -2.17M | -2.47M | -2.81M |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.53M | -3.94M | -15.14M | -12.13M | -27.53M | -11.46M |
| Pre Tax Income | -4.67M | -3.96M | -15.42M | -11.96M | -27.42M | -11.12M |
| Net Income | -3.77M | -3.36M | -14.41M | -11.43M | -27.42M | -11.12M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | -0.087 | -1.364 | -0.727 | -1.715 | -0.452 |
| EBIT | -4.53M | -3.94M | -15.14M | -11.97M | -27.53M | -11.46M |
| EBITDA | -3.9M | -3.13M | -14.33M | -11.34M | -19.47M | -11.46M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
